* We recommend a score >= 0.08 for meaningful Gene-Disease associations
GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | ![]() | DisGeNet_sourceDB |
1500 | CTNND1 | C0024121 | Lung Neoplasms | 0.0060152784980537 | BEFREE;LHGDN |
1500 | CTNND1 | C1458155 | Mammary Neoplasms | 0.0057405517138406 | BEFREE;LHGDN |
1500 | CTNND1 | C0027627 | Neoplasm Metastasis | 0.00548018030694475 | BEFREE;LHGDN |
1500 | CTNND1 | C0033578 | Prostatic Neoplasms | 0.0054658249296275 | LHGDN |
1500 | CTNND1 | C0007137 | Squamous cell carcinoma | 0.00383181960166615 | BEFREE;LHGDN |
1500 | CTNND1 | C0001418 | Adenocarcinoma | 0.00328236603323995 | BEFREE;LHGDN |
1500 | CTNND1 | C2239176 | Liver carcinoma | 0.00328236603323995 | BEFREE;LHGDN |
1500 | CTNND1 | C0025202 | melanoma | 0.00328236603323995 | BEFREE;LHGDN |
1500 | CTNND1 | C0242379 | Malignant neoplasm of lung | 0.0030219946263441 | BEFREE |
1500 | CTNND1 | C1306460 | Primary malignant neoplasm of lung | 0.002747267842131 | BEFREE |
1500 | CTNND1 | C0684249 | Carcinoma of lung | 0.002747267842131 | BEFREE |
1500 | CTNND1 | C0887833 | Carcinoma, Pancreatic Ductal | 0.00273291246481375 | LHGDN |
1500 | CTNND1 | C0206698 | Cholangiocarcinoma | 0.00273291246481375 | LHGDN |
1500 | CTNND1 | C0030297 | Pancreatic Neoplasm | 0.00273291246481375 | LHGDN |
1500 | CTNND1 | C0007131 | Non-Small Cell Lung Carcinoma | 0.0019230874894917 | BEFREE |
1500 | CTNND1 | C0678222 | Breast Carcinoma | 0.0019230874894917 | BEFREE |
1500 | CTNND1 | C0041296 | Tuberculosis | 0.0019230874894917 | BEFREE |
1500 | CTNND1 | C0699790 | Colon Carcinoma | 0.0016483607052786 | BEFREE |
1500 | CTNND1 | C0006142 | Malignant neoplasm of breast | 0.0013736339210655 | BEFREE |
1500 | CTNND1 | C0686619 | Secondary malignant neoplasm of lymph node | 0.0008241803526393 | BEFREE |
1500 | CTNND1 | C0596263 | Carcinogenesis | 0.0008241803526393 | BEFREE |
1500 | CTNND1 | C0029925 | Ovarian Carcinoma | 0.0008241803526393 | BEFREE |
1500 | CTNND1 | C0235974 | Pancreatic carcinoma | 0.0008241803526393 | BEFREE |
1500 | CTNND1 | C0346647 | Malignant neoplasm of pancreas | 0.0008241803526393 | BEFREE |
1500 | CTNND1 | C0178874 | Tumor Progression | 0.0008241803526393 | BEFREE |
1500 | CTNND1 | C0699791 | Stomach Carcinoma | 0.0005494535684262 | BEFREE |
1500 | CTNND1 | C0679362 | Tuberculosis, extrapulmonary | 0.0005494535684262 | BEFREE |
1500 | CTNND1 | C0221002 | Hyperparathyroidism, Primary | 0.0005494535684262 | BEFREE |
1500 | CTNND1 | C0007102 | Malignant tumor of colon | 0.0005494535684262 | BEFREE |
1500 | CTNND1 | C0346429 | Multiple malignancy | 0.0005494535684262 | BEFREE |
1500 | CTNND1 | C0750927 | Apraxia, Developmental Verbal | 0.0005494535684262 | BEFREE |
1500 | CTNND1 | C0009402 | Colorectal Carcinoma | 0.0005494535684262 | BEFREE |
1500 | CTNND1 | C1527249 | Colorectal Cancer | 0.0005494535684262 | BEFREE |
1500 | CTNND1 | C0024623 | Malignant neoplasm of stomach | 0.0005494535684262 | BEFREE |
1500 | CTNND1 | C0861352 | Lobular Neoplasia | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C1282496 | Metastasis from malignant tumor of prostate | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0936223 | Metastatic Prostate Carcinoma | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C1140680 | Malignant neoplasm of ovary | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C1176475 | Ductal Carcinoma | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0262587 | Parathyroid Adenoma | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C1335302 | Pancreatic Ductal Adenocarcinoma | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C1512409 | Hepatocarcinogenesis | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C1519670 | Tumor Angiogenesis | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C1527349 | Ductal Breast Carcinoma | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C1708349 | Hereditary Diffuse Gastric Cancer | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C1883486 | Uterine Corpus Cancer | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C3549742 | Breast cancer, lobular | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0032580 | Adenomatous Polyposis Coli | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0001430 | Adenoma | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0004096 | Asthma | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0007103 | Malignant neoplasm of endometrium | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0007134 | Renal Cell Carcinoma | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0017638 | Glioma | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0020255 | Hydrocephalus | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0021367 | Mammary Ductal Carcinoma | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0022602 | Actinic keratosis | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0023418 | leukemia | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0023903 | Liver neoplasms | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0600139 | Prostate carcinoma | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0032927 | Precancerous Conditions | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0041316 | Lymph Node Tuberculosis | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0152013 | Adenocarcinoma of lung (disorder) | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0242621 | Isochromosomes | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0278601 | Inflammatory Breast Carcinoma | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0338106 | Adenocarcinoma of colon | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0349579 | Atypical Endometrial Hyperplasia | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0476089 | Endometrial Carcinoma | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0553580 | Ewings sarcoma | 0.0002747267842131 | BEFREE |
1500 | CTNND1 | C0553694 | Oropharyngeal disorders | 0.0002747267842131 | BEFREE |